As long as u woke up today, then life is good life is great
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You got to love this part --- more $$$ to add to the bottom line.
Even though Josie’s just started franchising, there are currently 8 stores open in 4 states with over 67 stores under contract for development over the next 5 years.
This was from Josies web page , but we know its now 11 stores
More info on josies yogurt
http://franchise.josiesyogurt.com/
All the stores now owned by U-Swrl
The table below details the number of stores operating under each brand:
U-Swirl
Company-Owned Stores 6
Franchise Stores 28
Aspen Leaf Yogurt
Company-Owned Stores 6
Franchise Stores 9
Yogurtini 28
Gracie Bleu 2
Josie's Frozen Yogurt 11
Total =90
SWRL
Upcoming Events
Date Event Reminder
8-Nov-13 Earnings announcement
RMCF
Upcoming Events
Date Event Reminder
7-Oct-13 Earnings announcement
Come on ROCKY unleash the swrl n go right here lets all make some $$$$$$
Love this part
When the company was founded in 2010, Revel Systems focused primarily on the fast food and retail industries, with its first system debuting at Lappert's Fish and Chips Store in Sausalito, California. Since then, its reach has extended to Little Caesar’s Pizza, Rocky Mountain Chocolate Factory (NASDAQ:RMCF), Popeye’s Louisiana Kitchen, and Illy Coffee, among others. In the retail sector, Revel has partnered with tech accessories company Belkin and secondhand clothing company Goodwill.
Lets get part of this and $$$$$
Last December, a collaboration between airport food and beverage provider OTG Management and Delta Air Lines (NYSE:DAL), as well as other airlines and airports, brought 7,000 Apple (NASDAQ:AAPL) iPads to NYC's La Guardia, Toronto Pearson International, and Minneapolis-St. Paul International airports, allowing travelers to order food and drinks directly to their gates.
Now, the iPad is continuing its move into high-traffic public spaces by expanding into college football. The new 26,500-seat stadium at Alabama State University has been fully outfitted with consumer-ready iPads by San Francisco-based Revel Systems, the leader of the iPad-based point-of-sale (POS) systems market. All 30 concession stands at the ASU Hornets' new stadium have been equipped with iPads loaded with Revel's software, which will grant facility managers the ability the monitor sales and progress in real time.
The new ASU stadium. Source: Convergence Design
The Revel iPad system has several other advantages over traditional POS devices and programs. First, the system does not require Internet connectivity to operate. Because Revel uses a unique hybrid of local network and cloud connection, data can stream to the cloud and be shared by all the Revel-running iPads without Wi-Fi. (Click here to read more on Revel's "True Offline Mode.")
This offline functionality has proven to be a vital feature already for the stadium, as the system's iPads were able to continue functioning during a power outage at a recent game. Moreover, Revel has said that its POS software runs up to 14% faster per transaction than a traditional POS system, allowing it to accommodate a higher volume of consumers. That is a huge consideration for a 26,500-seat stadium that was built with the potential to expand to 55,000 seats.
When the company was founded in 2010, Revel Systems focused primarily on the fast food and retail industries, with its first system debuting at Lappert's Fish and Chips Store in Sausalito, California. Since then, its reach has extended to Little Caesar’s Pizza, Rocky Mountain Chocolate Factory (NASDAQ:RMCF), Popeye’s Louisiana Kitchen, and Illy Coffee, among others. In the retail sector, Revel has partnered with tech accessories company Belkin and secondhand clothing company Goodwill.
The football stadium environment is similar to the fast food and retail markets, but it brings along with it huge scale, as thousands of people buy concessions over the course of a football game. Revel has claimed that its system is well-suited to environments that see major spikes in consumer demand -- for example, during a halftime break.
The tablet POS space is becoming more competitive, with several POS systems, like Registroid, AccuPOS, and Point of Sale running on Google's (NASDAQ:GOOG) Android OS. That last system, Point of Sale, is actually offered for free on the Google Play app store. Moreover, there are several other competitors in the space that run on iOS, like POSIOS, Square Register, and PayPal (NASDAQ:EBAY). The latter two are also available for free from the app store.
However, with its all-inclusive installation and service, quicker transaction speed, and full offline capability, Revel has positioned itself as a strong contender for stadium POS.
Read more: http://www.minyanville.com/sectors/technology/articles/Thanks-to-Revel-Systems-Apple2527s-iPad/9/16/2013/id/51781#ixzz2gzsR2dAY
I am on board with over 16000 shares long and strong.
Took a little bite today.
Tue Jul 23 10:33:26 2013 Buy 1586 IGXT Executed @ $0.6498
Account: xxxx-1424 Your Day buy order for 1586 IGXT at a limit price of $0.6498 was executed at $0.6498. See order # 1422 for details.
Ok i could not hold off anymore
Thu Jul 18 13:54:34 2013 Buy 803 IGXT Executed @ $0.66
Account: xxxx-1424 Your Day buy order for 803 IGXT at a limit price of $0.66 was executed at $0.66. See order # 1419 for details.
Ok , have my order in to buy 2500 shares at 0.59.
Guesses on PAR drug, I pulled this off yahoo board.I like the way he or she thinks.
"
jgusciora • Jul 12, 2013 12:21 PM
I am going to say insulin. Right now you have to inject insulin because of the digestive system. If you bypassed that with the film, wow would be blockbuster. Just dreaming I guess."
Sentiment: Strong Buy"
Can you say $$$$$$$$$$$$$$$$$$$ , money in the bank.
So am I. My friends are also
Concentration of Shares Held
16.90% Top Owners
16.90% Top 50 Owners
16.90% Top 20 Owners
16.90% Top 10 Owners
83.10% Other Owners
Other Owners
Average Turnover Rating
Very High
High
Moderate
Low
Name Shares Held Position Value % of Total
Holdings Outstanding
Shares Owned Investment Style
BluMont Capital Corporation 6.2 M $3.9 M 71.49 11.54% Low
Boudreau (Bernard J) 45.0 K $26.6 K 0.52 0.08% N/A
Cypress Capital Management Ltd... 1.1 M $771.8 K 13.15 2.30% Moderate
Melchers (Bernd J) 45.0 K $26.4 K 0.52 0.08% Low
WAY Fund Managers Limited 200.0 K $135.0 K 2.30 0.40% High
Zerbe (Horst G) 471.0 K $278.2 K 5.42 0.83% N/A
Zerbe (Ingrid) 573.1 K $338.5 K 6.60 1.01% N/A
Top Mutual Fund OwnersTop Mutual Fund Owners
13.15% Momentum
Average Turnover Rating
Very High
High
Moderate
Low
Name Shares Held Position Value % of Total
Holdings Outstanding
Shares Owned Investment Style
Name Shares Held Position Value % of Total
Holdings Outstanding
Shares Owned Investment Style
AGF Canadian Small Cap Fund 1.1 M $719.9 K 13.15 2.14%
Par deal = Drug that is on the flim, that helps with cardiac issues .IMO.
That's a good start for everyone, now for drugs that have become generic with in the last year. GOOD LUCK.
I would say you are 100 percent right in most cases.However i told people that me and my friends are buying a few days ago and watch for volume increase.It is happening but they are all investors 2 to 5 year hold.
We are buying because of our collect DD.
The next NEWS out will be Hugh . IMO.
Mine is around 80 thousand or so.I am a small fry compared to my friends , their totals aways make mine look very tiny.
I hope they will slow the buying down a little , because i am nowhere near my goal.
As promised , here is my order. Took a tiny tiny bite yoday to get the ball rolling.
Wed Jul 10 09:35:51 2013 Buy 360 IGXT Executed @ $0.6394
Account: xxxx-xxxx Your Day buy order for 360 IGXT at a limit price of $0.6394 was executed at $0.6394. See order # 1414 for details.
The answer to your private message-- not me today but my friends buying slowly and small amounts, as not to drive up the price to fast. Charts no, but it looks like its about to trend up by the charts ,we crossed the 50 and 200 day MA.
I am not at liberty to say what if any new things the DD found out. I can say IMO we will move up from here a lot faster then we did today. IMO the next news RELEASE will be MEGA.IMO of course.
Volume picking up just like I told you , my friends are just stating to take some of their starting positions.
This volume will slowly increase , IMO of course.
Its great to have so many friends with money to invest, yes I said invest, their not flippers.2 TO 5 YEAR investors.
Shorts better start to cover very soon, you heard it here first.
Canadian, no.
Close is a very relative term.
All I can say is we will go up from here. IMO of course.
relative term
The colloquial meaning for a relative term is that it is different for different people or situations. An example: someone who is 5 feet tall might think someone who is 5 feet six inches tall is tall, but someone who is 6 feet would think that that person is short. An atom is big compared to a quark, but it is very small when compared to a body cell. Fast food may be healthier than preserved food, but unhealthy compared to organic produce
GaryJPalys you asked ?
Why does everyone leave off Pacific Therapeutics?
INT0024 is making good progress!
They don't understand they true value and what it means for our bottom line , but I do $$$$$$$$$$$$$$$$$$$$,
Just one more of the vast reasons why I am investing and not trading IGXT
Sure , but I am an investor so you may be waiting for some time. Check out any of my old posts, if I take an investor position in something I wait it out for years if nothing fundamentally changes.
The real question is will you do some true DD AND IF YOU LIKE WHAT YOU SEE WILL YOU JOINT ME.
This is my buying thus far, I repeat just all buys
Symbol
Last
Trade
Change
$ %
Day's
Gain Qty Price Paid
Total Gain
$ %
Market Val Edit
013775101
Buy / Sell
0.5761 -0.0019 -0.33% -$10.46 17,460 $0.6156 -$765.68 -7.07% $10,058.71
05/10/2013
Sell
0.5761 -0.0019 -0.33% -$6.97 3,670 $0.64 -$241.42 -10.25% $2,114.29
05/10/2013
Sell
0.5761 -0.0019 -0.33% -$1.14 600 $0.6499 -$54.27 -13.57% $345.66
05/13/2013
Sell
0.5761 -0.0019 -0.33% -$12.84 6,760 $0.64 -$441.96 -10.19% $3,894.44
05/14/2013
Sell
0.5761 -0.0019 -0.33% -$1.84 970 $0.60 -$33.17 -5.60% $558.82
05/24/2013
Sell
0.5761 -0.0019 -0.33% -$1.58 833 $0.615 -$42.39 -8.12% $479.89
06/06/2013
Sell
0.5761 -0.0019 -0.33% -$1.90 1,000 $0.557 $9.11 1.61% $576.10
06/13/2013
Sell
0.5761 -0.0019 -0.33% -$3.44 1,810 $0.56 $19.15 1.87% $1,042.74
07/03/2013
Sell
I will pick up 1000 or so shares every two weeks , until the Par project details are revealed, then ramp up to about 5000 or so every two weeks. I will post my buys to show I put my money were my mouth is.
Picked up a very small amount today just to get the ball rolling.
Wed Jul 03 09:56:27 2013 Buy 1817 IGXT Executed @ $0.56
Account: xxxx-1424 Your Day buy order for 1817 IGXT at a limit price of $0.56 was executed at $0.56. See order # 1406 for details.
Not trying to pump here ,but I talked to some fellow investors of mine and they like what they have heard , They did a lot of DD and will start taking positions just like me.
By the way they are investors not flippers-- at least 2 to 5 year hold for them. Get ready for the volume to slowly uptick. Slowly because, like me they will buy small amounts every weak and that way they don't drive the price up for now.
Here's what's in store for us.
Forfivo™ - indicated for Major Depressive Disorder
Forfivo™ (Bupropion extended-release) is a new product opportunity formulated using VersaTab™, IntelGenx’ proprietary controlled release tablet technology. Bupropion is approved by the FDA up to 450 mg for the treatment of major depressive disorder but was, until now, only available in 150 mg and 300 mg tablets. Forfivo™ completes the dosing options for physicians who currently prescribe multiples of lower strengths to provide patients with 450 mg of bupropion in a single tablet. Forfivo™ was developed to decrease the risk of dosing errors, improve patient compliance and therefore efficacy. Forfivo™ extended-release of bupropion blunts peak plasma concentrations compared to the instant release formulations, which should decrease the risk of seizures. Forfivo™ was approved by the FDA in 2011 and is currently licensed and marketed in the US through a partnership with Edgemont Pharmaceuticals LLC. IntelGenx is currently looking for a partnership or alliance opportunity to commercialize Forfivo™ in markets other than the US.
Rizatriptan film – indicated for Migraine
IntelGenx’ rizatriptan film is a new product opportunity co-developed in partnership with RedHill Biopharma (“RedHill”) and formulated using VersaFilm™, IntelGenx’ proprietary thin film technology. Rizatriptan is a selective 5-HT1B/1D receptor agonist indicated for the treatment of migraine. Compared to other triptan-based medications, rizatriptan demonstrates the highest efficacy and exhibits the shortest Tmax providing a quick onset of action for migraine sufferers. Rizatriptan is also indicated for the treatment of migraine attacks in children and elderly who could both benefit from the ease of administration of the film formulation. The rizatriptan film demonstrated bioequivalence in a successful pivotal clinical trial compared to the reference listed drug Maxalt MLT®. IntelGenx submitted a 505(b)(2) New Drug Application for regulatory approval to the U.S. Food and Drug Administration in Q1 2013. According to Merck's most recent annual report, sales of Maxalt® were $638 million in 2012. IntelGenx and RedHill are currently looking for a partnership or alliance opportunity to commercialize the rizatriptan film.
Tadalafil film – indicated for Erectile Dysfunction
IntelGenx’ tadalafil film is a new product opportunity formulated using VersaFilm™, IntelGenx’ proprietary thin film technology. Tadalafil is one of the three major PDE5 inhibitors in the erectile dysfunction market. Compared with the competitors, tadalafil shows longer duration of action and less food effect. IntelGenx’ tadalafil film offers an improved discrete dosage form that does not require water intake. IntelGenx tadalafil film formulations have been tested in various clinical trials to improve the pharmacokinetics and optimize the formulation. The latest formulation is planned to be tested in a pilot study in Q4 2012. IntelGenx is currently looking for a partnership or alliance opportunity to complete development and commercialize the tadalafil film.
INT0028 – indicated for Neuropathic Pain Management
INT0028 is a new product opportunity formulated using AdVersa™, IntelGenx’ proprietary muco-adhesive tablet technology. INT0028 is an improved product containing dronabinol (THC) for the symptomatic management of neuropathic pain. Marinol® is currently approved as an antiemetic but the analgesic properties of its active ingredient, dronabinol, is vastly recognized. When compared with Marinol® in a pilot clinical trial, INT0028 doubled the bioavailability of the active dronabinol while decreasing the plasma levels of the unwanted psychoactive metabolites. Therefore, INT0028 is designed to increase efficacy, avoid undesired psychotropic side effects, reduce degradation and decrease metabolisation compared with currently marketed formulations of dronabinol. INT0028 is formulated using patented and patent pending technology. IntelGenx is currently looking for a partnership or alliance opportunity to complete development and commercialize INT0028.
Animal health products
VetaFilm is designed to facilitate the administration of medication and promote compliance and the acceptability of medication regimes. VetaFilm has the potential to replace invasive administration procedures, improve animal compliance and avoid the tendency of animals to spit medications. VetaFilm is formulated to rapidly hydrate upon contact with the tongue and cannot be spat out due to its adhesive formulation. VetaFilm administration does not require water or chewing and offers enticing flavour options and appealing scents for increased acceptability. We are currently combining our VetaFilm technology with various active ingredients but remain interested in partnerships or alliances opportunities to complete development and commercialization of animal health products based on VetaFilm technology.
69 when you factor the warrants in, Still way undervalued even at 3.00 dollars.
Besides the cash will show up on the next balance sheet.
Quote for-- Aegis
" It got hit fairly hard the last few days of May; a small overhang of warrants remains from a financing a few years ago. I expect that will get chewed through shortly, and we'll have that cash on the balance sheet "
Get the price down a little lower and I will pick up more shares.
Got to love this
Fully Diluted Shares: 69 Million
Float Shares: 41.19 Million
Come on folks look at our friends
Current partners include, Edgemont Pharma, Azur Pharma, Dava Pharmaceuticals, RedHill Biopharma, and PAR Pharmaceuticals. We are in discussions with other potential partners for some of our other products.
3.00 dollars is nothing
Have over 20000 shares and counting.
Here are the owners and amounts.Name and Address Beneficial Percent of
Of Owner Ownership Class
Horst G. Zerbe(1) 4,997,143.5 (1) 10.0%
Ingrid Zerbe(2) 5,967,606.5 (2) 11.9%
Bernard J. Boudreau (3) 125,588 (3) *
Ian Troup(4) 100,000 (4) *
Paul A. Simmons(5) 157,500 (5) *
Bernd J. Melchers(6) 145,000 (6) *
John Marinucci(7) 75,000 (7) *
Rajiv Khosla(8) 56,250 (8) *
All directors and officers as a group (8 persons) 11,624,088 23.1%
BluMont Capital Corporation(9) 6,467,645 (9) 12.8%
Come on mike , here is what we have been waiting for --MIKE IT HAPPEN
.....How renewable energy could beat natural gas to the future
By Todd Woody | Quartz – 15 hours ago....Email0
Share0Print.....
We’ve taken the US Energy Information Administration (EIA) to task for its projections of future energy production and consumption that assumes the nation’s fossil fuel addiction will continue until the dinosaur juice runs dry.
Well, today the agency threw caution to the wind and focused on an alternative reality as part of its Annual Energy Outlook, due to be released on May 2. In the latest chapter, EIA examined what the world might look like in 2040 if current renewable energy incentives do not end in 2014 and 2016 as scheduled.
Under that scenario, green energy production grows, accounting for around 23% of total electricity generation in 2040, compared to 16% if business as usual continues. Given the skyrocketing growth in solar and wind generation over the past several years—half of America’s solar capacity was installed just in 2012—that forecast still seems conservative.
It doesn’t take into account, for instance, the likelihood that renewable energy will become cost competitive with fossil fuels, even without subsidies, due to technological breakthroughs and economies of scale. In fact, in some areas of the US with high electricity costs, such as California, that’s already starting to happen.
But here’s the interesting thing about even the EIA’s conservative forecast: The increase in renewable energy production starts to displace natural gas. (Nuclear power also takes a hit.) The agency estimates that electricity generation from natural gas-fired power plants would be 13% to 16% lower in 2040 compared to its standard forecasts. Not good news for all those investors betting on the shale gas boom.
But good news for the planet. Carbon dioxide emissions from energy productions would declined between 1.7% and 2.8% compared to business as usual, according to the EIA. Electricity prices would also drop between 3.9% and 6.3%.
The loss of tax revenues from extending current renewable energy subsidies would be $4 billion. Not calculated are the lower healthcare costs from eliminating emission of pollutants from power plants associated with heart and lung disease.
Coming up on the 60 days--- lets se if the new CEO can get things done or not.Get the SPA done IF YOU TRUELY WAHT TO MAKE IT AS OUR CEO.
acquisition expands biofuel production in South East Asia
Press Release: W2 Energy, Inc. – Tue, Feb 5, 2013 8:30 AM EST....Email 0Recommend1Tweet0Share0Print.....RELATED QUOTES..Symbol Price Change
WTWO 0.0003 0.00
......
GUELPH, Ontario, Feb. 5, 2013 /PRNewswire/ -- W2 Energy, Inc. (WTWO) is pleased to report it has signed a binding memorandum agreement to purchase 51% of AM Biofuels http://www.ambiofuels.com.my of Pasir Gudang Port of Johor Malaysia.
The company has signed and Memorandum Of Understanding (MOU) to buy 51% of the company from the shareholders of AM Biofuels.
This strategic acquisition expands W2 Energy's fuel business in South East Asia as the company continues to execute on is business plan of production, blending and distribution of bio and synthetic fuels.
AM Biodiesel's plant, licensed under Malaysian Palm Oil Council, has the capacity of 30,000 Metric Tons per year of Biodiesel production. The plant is a multi feedstock technology based on the esterification process. AM Biofuels was fully commissioned in end of 2010. The plant is currently in operation and plans to produce 20,000 MT of Palm biodiesel within 2103.
The company is located in Pasir Gudang Port of Johor Malaysia, which is one of the biggest Oleo Chemical centers in Asia. The factory is situated on a 10,000 sq. meters of prime land, within the port of Pasir Gudang vicinity, in the Pasir Gudang industrial zone. Pasir Gudang Port is facing Singapore, and only 30 kilometers away from Singapore border. Singapore is the world largest trading hub for oils, petrochemicals, and biofuel.
In addition to the biodiesel refinery, the Plant has several other useful facilities, 6 storage tanks of 300 MT each, 6 tanks for Bunker Oil of 20,000 liters each, 2 covered warehouses of approximately 2,000 sq. meters each. W2 Energy intends to commission and operate a Coal/Water/Biodiesel Slurry fuel production plant directly on the site.
Mr. Michael McLaren, CEO of W2 Energy, states, "Another strategic acquisition put in place by Dr. Wan Hasni, our new CFO. With AM Biofuels and Ecobound fuel production systems, W2 Energy is poised to enter the 'clean fuel market' of Asia. Malaysia consumes about 50,000 barrels of fuel oils per day while Indonesia consumes about 200,000 barrels per day of fuel oils. The South East Asian region in total consumes about 500,000 barrels per day of fuel oil. W2 Energy will install and commission a #6 fuel oil replacement plant on the site and distribute the product through Ecobound Fuel Production Systems production license."
The acquisition is valued at $5,500,000 US and W2 energy will receive a total of 51% shares of AM Biofuels for 55,000,000 W2 Energy shares at a deemed value of US 0.10 cents per share.
The agreement also states the parties have agreed to complete and further due diligence, consents and approvals and execute the SPA (Stock Purchase Agreement) within 60 days of signing the MOU.
Were did everyone go?
Come on mike give us any news, Us shareholders don't need to be treated like this.Give US news good or bad, please.
Agree, lets get it done.Mike for the love of GOD , give us an update good or bad.
Here just waiting on news, 30 days have come .Let us know if the deal is done or not.
Come on Mike give us news one way or another, deal done or deal fell apart. 30 days have come
..W2 Energy Signs Agreement To Purchase 51% Of Ecobound Fuel Production Systems
Strategic acquisition enables expansion in the fuel production and distribution business
Press Release: W2 Energy, Inc. – Thu, Jan 31, 2013 8:15 AM EST..
If so what did they say.You can post it here because i know for a fact w2 energy gives out no insider info.So lets have and prove what you say is true.